Characterization of Neurophysiological and Behavioral Changes, MRI Brain Volumetry and 1H MRS in zQ175 Knock-In Mouse Model of Huntington's Disease
Taneli Heikkinen, Larry C. Park(CHDI Foundation)
Cited by 324
Related Papers
Nuclear factor (erythroid-derived 2)-like 2 (NRF2) drug discovery: Biochemical toolbox to develop NRF2 activators by reversible binding of Kelch-like ECH-associated protein 1 (KEAP1)
|Archives of Biochemistry and Biophysics|2017|45
Global Rhes knockout in the Q175 Huntington’s disease mouse model
|PLoS ONE|2021|14
Identification and Optimization of RNA-Splicing Modulators as Huntingtin Protein-Lowering Agents for the Treatment of Huntington’s Disease
|Journal of Medicinal Chemistry|2023|7